Travere Therapeutics, Inc.
TVTX
$42.84
-$0.67-1.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 264.68M | 322.80M | 254.53M | 319.54M | 322.24M |
| Total Receivables | 88.50M | 81.43M | 84.48M | 40.22M | 36.48M |
| Inventory | 6.36M | 5.88M | 5.55M | 4.09M | 3.93M |
| Prepaid Expenses | 33.15M | 27.46M | 26.55M | 15.72M | 11.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 392.68M | 437.57M | 371.11M | 379.57M | 374.17M |
|
|
|||||
| Total Current Assets | 392.68M | 437.57M | 371.11M | 379.57M | 374.17M |
| Net Property, Plant & Equipment | 13.30M | 14.60M | 15.78M | 16.90M | 18.05M |
| Long-term Investments | 752.00K | 753.00K | 753.00K | 753.00K | 753.00K |
| Goodwill | 752.00K | 753.00K | 753.00K | 753.00K | 753.00K |
| Total Other Intangibles | 109.29M | 113.12M | 108.68M | 104.85M | 103.06M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 39.17M | 39.16M | 42.25M | 53.24M | 52.76M |
| Total Assets | 555.19M | 605.19M | 538.58M | 555.31M | 548.80M |
|
|
|||||
| Total Accounts Payable | 12.91M | 24.80M | 18.23M | 19.13M | 15.37M |
| Total Accrued Expenses | 104.41M | 126.04M | 105.76M | 81.68M | 77.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.02M | 5.88M | 5.73M | 74.43M | 74.22M |
| Total Finance Division Other Current Liabilities | 2.10M | 3.19M | 5.35M | 14.29M | 15.76M |
| Total Other Current Liabilities | 2.10M | 3.19M | 5.35M | 14.29M | 15.76M |
| Total Current Liabilities | 125.44M | 159.90M | 135.07M | 189.54M | 182.46M |
|
|
|||||
| Total Current Liabilities | 125.44M | 159.90M | 135.07M | 189.54M | 182.46M |
| Long-Term Debt | 312.08M | 311.72M | 311.37M | 311.02M | 310.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.57M | 11.13M | 12.65M | 14.12M | 15.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.38M | 7.60M | 5.93M | 7.88M | 7.27M |
| Total Liabilities | 456.46M | 490.36M | 465.02M | 522.56M | 515.98M |
|
|
|||||
| Common Stock & APIC | 1.61B | 1.59B | 1.55B | 1.53B | 1.52B |
| Retained Earnings | -1.51B | -1.47B | -1.48B | -1.50B | -1.49B |
| Treasury Stock & Other | -1.06M | -1.19M | -1.05M | -812.00K | -843.00K |
| Total Common Equity | 98.73M | 114.83M | 73.56M | 32.75M | 32.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.73M | 114.83M | 73.56M | 32.75M | 32.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 98.73M | 114.83M | 73.56M | 32.75M | 32.82M |
|
|
|||||